insider24.ch
Back to the feed

Shareholding disclosure

Santhera Pharmaceuticals Holding AG

inSanthera Pharmaceuticals Holding AG

Declared position

97.06%

Threshold

Crossed downwards

Timeline

Published

07.03.2023

Transaction

28.02.2023

Voting rights breakdown

Voting rights acquired32.28%
Voting rights sold97.06%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAN3600053

Beneficial owner

Santhera Pharmaceuticals Holding AG

Declared address

Santhera Pharmaceuticals Holding AG, Pratteln

acquisition and disposal of shares on February 28, 2023; also regarding certain sale positions

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open